Registro:

Referencias:

• Bouzat, C., New insights into the structural bases of activation of Cys-loop receptors (2012) J. Physiol. Paris, 106, pp. 23-33
• Unwin, N., Refined structure of the nicotinic acetylcholine receptor at 4-Å resolution (2005) J. Mol. Biol., 346, pp. 967-989
• Albuquerque, E.X., Pereira, E.F., Alkondon, M., Rogers, S.W., Mammalian nicotinic acetylcholine receptors: From structure to function (2009) Physiol. Rev., 89, pp. 73-120
• Chernyavsky, A.I., Arredondo, J., Marubio, L.M., Grando, S.A., Differential regulation of keratinocyte chemokinesis and chemotaxis through distinct nicotinic receptor subtypes (2004) J. Cell Sci., 117, pp. 5665-5679
• Fasoli, F., Gotti, C., Structure of neuronal nicotinic receptors (2015) Curr. Top. Behav. Neurosci., 23, pp. 1-17
• Shen, J.X., Yakel, J.L., Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system (2009) Acta Pharmacol. Sin., 30, pp. 673-680
• Andersen, N., Corradi, J., Sine, S.M., Bouzat, C., Stoichiometry for activation of neuronal α7 nicotinic receptors (2013) Proc. Natl. Acad. Sci. U.S.A., 110, pp. 20819-20824
• De Rosa, M.J., Dionisio, L., Agriello, E., Bouzat, C., Esandi, M.D.C., α7 nicotinic acetylcholine receptor modulates lymphocyte activation (2009) Life Sci., 85, pp. 444-449
• De Rosa, M.J., Esandi, M.D.C., Garelli, A., Rayes, D., Bouzat, C., Relationship between α7 nAChR and apoptosis in human lymphocytes (2005) J. Neuroimmunol., 160, pp. 154-161
• Kawashima, K., Fujii, T., Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function (2004) Front. Biosci., 9, pp. 2063-2085
• Kawashima, K., Fujii, T., Moriwaki, Y., Misawa, H., Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function (2012) Life Sci., 91, pp. 1027-1032
• Bencherif, M., Lippiello, P.M., Lucas, R., Marrero, M.B., α7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases (2011) Cell Mol. Life Sci., 68, pp. 931-949
• De Jonge, W.J., Ulloa, L., The α7 nicotinic acetylcholine receptor as a pharmacological target for inflammation (2007) Br. J. Pharmacol., 151, pp. 915-929
• Filippini, P., Cesario, A., Fini, M., Locatelli, F., Rutella, S., The Yin and Yang of non-neuronal α7-nicotinic receptors in inflammation and autoimmunity (2012) Curr. Drug Targets, 13, pp. 644-655
• Nizri, E., Brenner, T., Modulation of inflammatory pathways by the immune cholinergic system (2013) Amino Acids, 45, pp. 73-85
• Pohanka, M., α7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology (2012) Int. J. Mol. Sci., 13, pp. 2219-2238
• Tracey, K.J., Reflex control of immunity (2009) Nat. Rev. Immunol., 9, pp. 418-428
• Campbell, K.S., Hasegawa, J., Natural killer cell biology: An update and future directions (2013) J. Allergy Clin. Immunol., 132, pp. 536-544
• Poggi, A., Zocchi, M.R., NK cell autoreactivity and autoimmune diseases (2014) Front. Immunol., 5, p. 27
• Ferlazzo, G., Morandi, B., Cross-talks between natural killer cells and distinct subsets of dendritic cells (2014) Front. Immunol., 5, p. 159
• Barreira Da Silva, R., Münz, C., Natural killer cell activation by dendritic cells: Balancing inhibitory and activating signals (2011) Cell Mol. Life Sci., 68, pp. 3505-3518
• Ferlazzo, G., Münz, C., Dendritic cell interactions with NK cells from different tissues (2009) J. Clin. Immunol., 29, pp. 265-273
• Zwirner, N.W., Domaica, C.I., Cytokine regulation of natural killer cell effector functions (2010) Biofactors, 36, pp. 274-288
• Fogel, L.A., Yokoyama, W.M., French, A.R., Natural killer cells in human autoimmune disorders (2013) Arthritis Res. Ther., 15, p. 216
• Tian, Z., Gershwin, M.E., Zhang, C., Regulatory NK cells in autoimmune disease (2012) J. Autoimmun., 39, pp. 206-215
• Shifrin, N., Raulet, D.H., Ardolino, M., NK cell self tolerance, responsiveness and missing self recognition (2014) Semin. Immunol., 26, pp. 138-144
• Hsueh, C.M., Chen, S.F., Lin, R.J., Chao, H.J., Cholinergic and serotonergic activities are required in triggering conditioned NK cell response (2002) J. Neuroimmunol., 123, pp. 102-111
• Qiu, Y.H., Peng, Y.P., Jiang, J.L., Wang, J.J., Effect of acetylcholine on in vitro IL-2 production and NK cell cytotoxicity of rats (2004) Lymphology, 37, pp. 31-38
• Hao, J., Shi, F.D., Abdelwahab, M., Shi, S.X., Simard, A., Whiteaker, P., Lukas, R., Zhou, Q., Nicotinic receptor β2 determines NK cell-dependent metastasis in a murine model of metastatic lung cancer (2013) PLoS ONE, 8
• Chernyavsky, A.I., Arredondo, J., Galitovskiy, V., Qian, J., Grando, S.A., Structure and function of the nicotinic arm of acetylcholine regulatory axis in human leukemic T cells (2009) Int. J. Immunopathol. Pharmacol., 22, pp. 461-472
• Landais, E., Liautaud-Roger, F., Antonicelli, F., Lymphocytes prime activation is required for nicotine-induced calcium waves (2010) Front. Biosci., 2, pp. 928-939
• Qian, J., Galitovskiy, V., Chernyavsky, A.I., Marchenko, S., Grando, S.A., Plasticity of the murine spleen T-cell cholinergic receptors and their role in in vitro differentiation of naive CD4 T cells toward the Th1, Th2 and Th17 lineages (2011) Genes Immun., 12, pp. 222-230
• Chijioke, O., Münz, C., Dendritic cell derived cytokines in human natural killer cell differentiation and activation (2013) Front. Immunol., 4, p. 365
• Romee, R., Leong, J.W., Fehniger, T.A., Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer (2014) Scientifica, 2014
• DaCosta, C.J., Free, C.R., Corradi, J., Bouzat, C., Sine, S.M., Single-channel and structural foundations of neuronal α7 acetylcholine receptor potentiation (2011) J. Neurosci., 31, pp. 13870-13879
• Lam, R.A., Chwee, J.Y., Le Bert, N., Sauer, M., Pogge Von Strandmann, E., Gasser, S., Regulation of self-ligands for activating natural killer cell receptors (2013) Ann. Med., 45, pp. 384-394
• Mistry, A.R., O'Callaghan, C.A., Regulation of ligands for the activating receptor NKG2D (2007) Immunology, 121, pp. 439-447
• Wang, H., Liao, H., Ochani, M., Justiniani, M., Lin, X., Yang, L., Al-Abed, Y., Ulloa, L., Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis (2004) Nat. Med., 10, pp. 1216-1221
• Kawashima, K., Fujii, T., The lymphocytic cholinergic system and its contribution to the regulation of immune activity (2003) Life Sci., 74, pp. 675-696
• Sun, Z., Smyth, K., Garcia, K., Mattson, E., Li, L., Xiao, Z., Nicotine inhibits memory CTL programming (2013) PLoS ONE, 8
• Hao, J., Simard, A.R., Turner, G.H., Wu, J., Whiteaker, P., Lukas, R.J., Shi, F.D., Attenuation of CNS inflammatory responses by nicotine involves α7 and non-α7 nicotinic receptors (2011) Exp. Neurol., 227, pp. 110-119
• Simard, A.R., Gan, Y., St-Pierre, S., Kousari, A., Patel, V., Whiteaker, P., Morley, B.J., Shi, F.D., Differential modulation of EAE by α9∗- and β2∗-nicotinic acetylcholine receptors (2013) Immunol. Cell Biol., 91, pp. 195-200
• Hoogduijn, M.J., Cheng, A., Genever, P.G., Functional nicotinic and muscarinic receptors on mesenchymal stem cells (2009) Stem Cells Dev., 18, pp. 103-112
• Wu, J.C., Chruscinski, A., De Jesus Perez, V.A., Singh, H., Pitsiouni, M., Rabinovitch, M., Utz, P.J., Cooke, J.P., Cholinergic modulation of angiogenesis: Role of the 7 nicotinic acetylcholine receptor (2009) J. Cell Biochem., 108, pp. 433-446
• Razani-Boroujerdi, S., Boyd, R.T., Dávila-García, M.I., Nandi, J.S., Mishra, N.C., Singh, S.P., Pena-Philippides, J.C., Sopori, M.L., T cells express α7-nicotinic acetylcholine receptor subunits that require a functional TCR and leukocyte-specific protein tyrosine kinase for nicotine-induced Ca2+ response (2007) J. Immunol., 179, pp. 2889-2898
• Schedel, A., Thornton, S., Schloss, P., Klüter, H., Bugert, P., Human platelets express functional α7-nicotinic acetylcholine receptors (2011) Arterioscler. Thromb. Vasc. Biol., 31, pp. 928-934
• Dajas-Bailador, F., Wonnacott, S., Nicotinic acetylcholine receptors and the regulation of neuronal signalling (2004) Trends Pharmacol. Sci., 25, pp. 317-324
• Sharma, G., Vijayaraghavan, S., Nicotinic receptor signaling in nonexcitable cells (2002) J. Neurobiol., 53, pp. 524-534
• Mandal, A., Viswanathan, C., Natural killer cells: In health and disease (2015) Hematol. Oncol. Stem Cell Ther., 8, pp. 47-55
• Pavlov, V.A., Tracey, K.J., The cholinergic anti-inflammatory pathway (2005) Brain. Behav. Immun., 19, pp. 493-499
• Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.J., Pulendran, B., Palucka, K., Immunobiology of dendritic cells (2000) Annu. Rev. Immunol., 18, pp. 767-811
• Banchereau, J., Steinman, R.M., Dendritic cells and the control of immunity (1998) Nature, 392, pp. 245-252
• Cella, M., Sallusto, F., Lanzavecchia, A., Origin, maturation and antigen presenting function of dendritic cells (1997) Curr. Opin. Immunol., 9, pp. 10-16
• Egea, J., Buendia, I., Parada, E., Navarro, E., León, R., Lopez, M.G., Anti-inflammatory role of microglial α7 nAChRs and its role in neuroprotection (2015) Biochem. Pharmacol., 97, pp. 463-472
• Kalkman, H.O., Feuerbach, D., Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders (2016) Cell Mol. Life Sci., 73, pp. 2511-2530
• Hurst, R., Rollema, H., Bertrand, D., Nicotinic acetylcholine receptors: From basic science to therapeutics (2013) Pharmacol. Ther., 137, pp. 22-54
• Corradi, J., Bouzat, C., Understanding the bases of function and modulation of α7 nicotinic receptors: Implications for drug discovery (2016) Mol. Pharmacol.
• Suzuki, T., Hide, I., Matsubara, A., Hama, C., Harada, K., Miyano, K., Andrä, M., Nakata, Y., Microglial α7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role (2006) J. Neurosci. Res., 83, pp. 1461-1470
• Zdanowski, R., Krzyzowska, M., Ujazdowska, D., Lewicka, A., Lewicki, S., Role of α7 nicotinic receptor in the immune system and intracellular signaling pathways (2015) Cent. Eur. J. Immunol., 40, pp. 373-379
• King, J.R., Kabbani, N., α7 nicotinic receptor coupling to heterotrimeric G proteins modulates RhoA activation, cytoskeletal motility, and structural growth (2016) J. Neurochem.
• King, J.R., Nordman, J.C., Bridges, S.P., Lin, M.K., Kabbani, N., Identification and characterization of a G protein-binding cluster in α7 nicotinic acetylcholine receptors (2015) J. Biol. Chem., 290, pp. 20060-20070
• Adamczyk, M., Brashear, R.J., Mattingly, P.G., Choline concentration in normal blood donor and cardiac troponin-positive plasma samples (2006) Clin. Chem., 52, pp. 2123-2124
• Kawashima, K., Fujii, T., Moriwaki, Y., Misawa, H., Horiguchi, K., Non-neuronal cholinergic system in regulation of immune function with a focus on α7 nAChRs (2015) Int. Immunopharmacol., 29, pp. 127-134
• Lueders, C.D., Müller, O., Storm, C., Möckel, M., Evaluation of a chemiluminescent assay for analysis of choline in human plasma and whole blood (2007) Lab. Med., 38, pp. 726-728
• Pacheco, R., Riquelme, E., Kalergis, A.M., Emerging evidence for the role of neurotransmitters in the modulation of T cell responses to cognate ligands (2010) Cent. Nerv. Syst. Agents Med. Chem., 10, pp. 65-83
• Weinstein, L.I., Revuelta, A., Pando, R.H., Catecholamines and acetylcholine are key regulators of the interaction between microbes and the immune system (2015) Ann. N.Y. Acad. Sci., 1351, pp. 39-51
• Mignini, F., Streccioni, V., Amenta, F., Autonomic innervation of immune organs and neuroimmune modulation (2003) Auton. Autacoid Pharmacol., 23, pp. 1-25
• Uteshev, V.V., α7 nicotinic ACh receptors as a ligand-gated source of Ca2+ ions: The search for a Ca2+ optimum (2012) Adv. Exp. Med. Biol., 740, pp. 603-638
• Uteshev, V.V., The therapeutic promise of positive allosteric modulation of nicotinic receptors (2014) Eur. J. Pharmacol., 727, pp. 181-185
• Arredondo, J., Chernyavsky, A.I., Webber, R.J., Grando, S.A., Biological effects of SLURP-1 on human keratinocytes (2005) J. Invest. Dermatol., 125, pp. 1236-1241
• Chimienti, F., Hogg, R.C., Plantard, L., Lehmann, C., Brakch, N., Fischer, J., Huber, M., Hohl, D., Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda (2003) Hum. Mol. Genet., 12, pp. 3017-3024
• Kawashima, K., Fujii, T., Moriwaki, Y., Misawa, H., Horiguchi, K., Reconciling neuronally and nonneuronally derived acetylcholine in the regulation of immune function (2012) Ann. N.Y. Acad. Sci., 1261, pp. 7-17
• Chatzidaki, A., Millar, N.S., Allosteric modulation of nicotinic acetylcholine receptors (2015) Biochem. Pharmacol., 97, pp. 408-417
• Williams, D.K., Wang, J., Papke, R.L., Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: Advantages and limitations (2011) Biochem. Pharmacol., 82, pp. 915-930
• Domaica, C.I., Fuertes, M.B., Uriarte, I., Girart, M.V., Sardañons, J., Comas, D.I., Di Giovanni, D., Zwirner, N.W., Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development (2012) PLoS ONE, 7
• Ziblat, A., Domaica, C.I., Spallanzani, R.G., Iraolagoitia, X.L., Rossi, L.E., Avila, D.E., Torres, N.I., Zwirner, N.W., IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness (2015) Eur. J. Immunol., 45, pp. 192-202
• Rossi, L.E., Avila, D.E., Spallanzani, R.G., Ziblat, A., Fuertes, M.B., Lapyckyj, L., Croci, D.O., Zwirner, N.W., Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression (2012) J. Leukoc. Biol., 91, pp. 321-331

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------